All Stories

  1. Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish nationwide cohort

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2019, Oxford University Press (OUP)

    Mr Peter Brønnum Nielsen

  2. Letter to the Editor

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, August 2019, Oxford University Press (OUP)

    Mr Peter Brønnum Nielsen

  3. Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review

    Article • Expert Review of Cardiovascular Therapy, October 2018, Taylor & Francis

    Mr Peter Brønnum Nielsen, Dr Sam Riahi

  4. Premature atrial complexes in an ischemic stroke population and risk of recurrent stroke: a systematic review

    Article • Expert Review of Cardiovascular Therapy, June 2017, Taylor & Francis

    Dr Sam Riahi, Mr Peter Brønnum Nielsen

  5. Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study

    Article • The Annals of Thoracic Surgery, April 2016, Elsevier

    Mr Peter Brønnum Nielsen

  6. Pharmacoepidemiological comparisons between acenocoumarol and dabigatran: interpretation of data reflecting clinical practice

    Article • EP Europace, February 2016, European Society of Cardiology

    Mr Peter Brønnum Nielsen

  7. Self-managed oral anticoagulant therapy: a call for implementation

    Article • Expert Review of Cardiovascular Therapy, February 2016, Taylor & Francis

    Mr Peter Brønnum Nielsen

  8. Recalibration of the HAS-BLED Score

    Article • CHEST Journal, February 2016, Elsevier

    Mr Peter Brønnum Nielsen

  9. β-Blockers in Atrial Fibrillation Patients With or Without Heart FailureCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, January 2016, Wolters Kluwer Health

    Mr Peter Brønnum Nielsen

  10. Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

    Article • Expert Review of Cardiovascular Therapy, September 2015, Taylor & Francis

    Mr Peter Brønnum Nielsen

  11. Atrial flutter and thromboembolic risk: a systematic review

    Article • Heart, July 2015, BMJ

    Mr Peter Brønnum Nielsen, Dr Sam Riahi

  12. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and BleedingCLINICAL PERSPECTIVE

    Article • Circulation, June 2015, Wolters Kluwer Health

    Mr Peter Brønnum Nielsen

  13. Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation

    Article • CHEST Journal, June 2015, Elsevier

    Mr Peter Brønnum Nielsen

  14. Using the CHA2DS2-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application

    Article • Canadian Journal of Cardiology, June 2015, Elsevier

    Mr Peter Brønnum Nielsen

  15. Comparison of Atrial Fibrillation Guidelines

    Article • Journal of General Internal Medicine, May 2015, Springer Science + Business Media

    Mr Peter Brønnum Nielsen

  16. Atrial Fibrillation Patients Categorized as “Not for Anticoagulation” According to the 2014 Canadian Cardiovascular Society Algorithm Are Not “Low Risk”

    Article • Canadian Journal of Cardiology, January 2015, Elsevier

    Mr Peter Brønnum Nielsen

  17. Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes

    Article • PLoS ONE, December 2014, PLOS

    Mr Peter Brønnum Nielsen

  18. Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis

    Article • Clinical Research in Cardiology, November 2014, Springer Science + Business Media

    Mr Peter Brønnum Nielsen

  19. Sex Differences in Treatment Quality of Self-Managed Oral Anticoagulant Therapy: 6,900 Patient-Years of Follow-Up

    Article • PLoS ONE, November 2014, PLOS

    Mr Peter Brønnum Nielsen

  20. The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score

    Article • CHEST Journal, November 2014, Elsevier

    Mr Peter Brønnum Nielsen

  21. Improvement of anticoagulant treatment using a dynamic decision support algorithm

    Article • Thrombosis Research, March 2014, Elsevier

    Mr Peter Brønnum Nielsen

  22. Monitoring of anticoagulant therapy applying a dynamic statistical model

    Article • Computer Methods and Programs in Biomedicine, June 2013, Elsevier

    Mr Peter Brønnum Nielsen